PIA
CDLX icon

Piedmont Investment Advisors’s Cardlytics CDLX Stock Holding History

Piedmont Investment Advisors’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10
Closed -$2K – 1244
2018
Q2 		$2K Buy
+10
New +$1.85K ﹤0.01% 2554

Other funds holding CDLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SRFM
Shannon River Fund Management New York $524M AUM 90.54% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Piedmont Investment Advisors's CDLX Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Cardlytics (CDLX) in Q3 2018, closing a stake of 10 shares — an estimated $2K sold.

Piedmont Investment Advisors first reported a position in CDLX in Q2 2018 and held it in 1 quarter. The position peaked at $2K in Q2 2018. 58 funds tracked by Wall St. Rank hold CDLX as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Cardlytics position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 10 Cardlytics shares in Q3 2018, an estimated $2K.
  • Piedmont Investment Advisors first reported a position in Cardlytics in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Cardlytics position peaked at $2K in Q2 2018.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.